Dr. Jennifer A. Doudna is the Li Ka Shing Chancellor's Chair and a Professor in the Departments of Chemistry and of Molecular and Cell Biology at the University of California, Berkeley. Her groundbreaking development of CRISPR-Cas9 as a genome-engineering technology, with collaborator Emmanuelle Charpentier, earned the two the 2020 Nobel Prize in Chemistry and forever changed the course of human and agricultural genomics research.

Register at https://duke.is/matthews-2026

Speaker(s): Jennifer A. Doudna, PhD, Howard Hughes Medical Institute and Innovative Genomics Institute University of California Berkeley and UCSF/Gladstone Institutes

Duke Event Series: THE THOMAS J. MATTHEWS ENDOWED LECTURESHIP

Duke Event Co-Sponsor(s): School of Medicine (SOM), Biochemistry, Biomedical Engineering (BME), Cell Biology, Center for AIDS Research (CFAR), Department of Head and Neck Surgery & Communication Sciences, Department of Medicine, Department of Surgery, Duke Global Health Institute (DGHI), Duke Human Vaccine Institute (DHVI), Duke-Margolis Center for Health Policy, Molecular Genetics and Microbiology (MGM), Neurobiology, Pharmacology and Cancer Biology